HomeVideoIt's All About-Juvenile Diabetes Research Foundation-Wichita-Improve Lives

It's All About-Juvenile Diabetes Research Foundation-Wichita-Improve Lives

List of all video credits is specified here http://broadcaster.beazil.net/public/credits/youtube/videos/41708 Wichita, city, seat (1870) of Sedgwick county, south-central Kansas, U.S. It lies on the Arkansas River near the mouth of the Little Arkansas, about 140 miles (225 km) southwest of Topeka. The city site is a gently rolling plain at an elevation of about 1,300 feet (400 metres). Summers are hot and winters cool; precipitation is moderate and falls mainly during the warm months. Wichita, the largest city in the state, is at the heart of a three-county metropolitan area. Nearby communities include Park City (north), Andover (east), and Derby and Haysville (south). Inc. city, 1871. Area city, 139 square miles (360 square km). Pop. (2000) 344,284; Wichita Metro Area, 571,166; (2010) 382,368; Wichita Metro Area, 623,061. Wichita was founded in 1864 as a trading post on the site of a village of the Wichita Indians. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone people need to get energy from food. T1D strikes both children and adults at any age and suddenly. Its onset has nothing to do with diet or lifestyle. Though T1D’s causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers play a role. There is currently nothing you can do to prevent it, and there is no cure. Type 1 diabetes strikes both children and adults at any age. It comes on suddenly, causes dependence on injected or pumped insulin for life, and carries the constant threat of devastating complications. Diabetes can affect how you feel each day. If your blood glucose level is too high or too low (hypoglycemia), you may not feel well. JDRF is leading the way in establishing measurement guidelines and holding itself accountable to supporters. JDRF has developed transparent organizational goals, as well as a set of research and advocacy objectives and outcomes for the current year by which organizational success will be measured. Measurements include:
– Initiating new clinical trials for artificial pancreas systems
– Developing new approaches to encapsulating islets
– Beginning proof-of-concept clinical trials with existing islet encapsulation approaches
– Trials demonstrating slowing progression of T1D in at-risk patients
– Effectiveness of approved T2D drugs tested in T1D
– Partnering to develop new T1D biomarkers
– Congress enacts $150 million extension of Special Diabetes Program at the National Institutes of Health JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
The main points are –
glycemic control comparison,repaglinide,oral hypoglycemic agents,ketonuria,Glucose,Clinical Trial,Traveling with Diabetes,treatment of diabetes,adult-onset diabetes,sugar breakdown,insulin dependent,diabetes management,impaired glucose tolerance,acetohexamide,estimated average glucose,raise money,glycemic targets,volunteering,Promise to Remember Me,Get Personal Support,injection site rotation,diabetic retinopathy,DSME,A1C Limitations,diabetes advocacy,advocating for government support,Glipizide,Aaron Kowalski,six international affiliates,FPG value,OGTT,donation,Veterans Affairs Diabetes Trial,brittle diabetes,funding research,save a life,diabetes care concepts,diabetes symptoms,become a volunteer,prone to ketoacidosis,diabetes death rate,T1D patterns,Type 2 Diabetes,speak out,learn more,Research Pathways,Beta Cell Regeneration,insulin independent remission,Glucose Modulating Agents,T1D complications,ACCORD Study,ketosis,TypeOnesie,Device,high blood glucose,Basal Insulin,World without T1D,Grant Management.


Previous post
It's All About-Research Funding-Riverside-Type None Diabetes
Next post
It's All About/Charitable Organization/Anaheim/Curing Type 1 Diabetes

Leave a Reply

Be the First to Comment!

Notify of